Xenopus as a screening tool in the drug discovery and development process

Wheeler, Grant (Principal Investigator)

Status	Finished
Effective start/end date	1/10/10 → 31/03/14

Funding

AstraZeneca: £22,499.99

The positive transcriptional elongation factor (P-TEFb) is required for neural crest specification
Hatch, V., Marin Barba, M., Moxon, S., Ford, C., Ward, N., Tomlinson, M., Desanlis, I., Hendry, A., Hontelez, S., van Krujsbergen, I., Veenstra, G. J., Munsterberg, A. & Wheeler, G., 15 Aug 2016, In: Developmental Biology. 416, 2, p. 361–372
Research output: Contribution to journal › Article › peer-review

Open Access
File

12 Citations (Scopus)

25 Downloads (Pure)